71 related articles for article (PubMed ID: 26548627)
1. A novel somatic MAPK1 mutation in primary ovarian mixed germ cell tumors.
Zou Y; Deng W; Wang F; Yu XH; Liu FY; Yang BC; Huang MZ; Guo JB; Xie QH; He M; Huang OP
Oncol Rep; 2016 Feb; 35(2):725-30. PubMed ID: 26548627
[TBL] [Abstract][Full Text] [Related]
2. Absence of
Zou Y; Huang MZ; Liu FY; Yang BC; Wang LQ; Wang F; Yu XH; Wan L; Wan XD; Xu XY; Li W; Huang OP; He M
Biomed Rep; 2015 Jan; 3(1):33-37. PubMed ID: 25469243
[TBL] [Abstract][Full Text] [Related]
3. RNF43 mutations are recurrent in Chinese patients with mucinous ovarian carcinoma but absent in other subtypes of ovarian cancer.
Zou Y; Wang F; Liu FY; Huang MZ; Li W; Yuan XQ; Huang OP; He M
Gene; 2013 Nov; 531(1):112-6. PubMed ID: 24001777
[TBL] [Abstract][Full Text] [Related]
4. Infrequent mutations of the PPP2R1A and PPP2R1B genes in patients with ovarian cancer.
Wang F; Zou Y; Liu FY; Yu XH; Huang H; Zhang N; Qi YY; Liu RF; Liu XY; Chen J; Huang OP; He M
Mol Med Rep; 2013 Jun; 7(6):1826-30. PubMed ID: 23588898
[TBL] [Abstract][Full Text] [Related]
5. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
[TBL] [Abstract][Full Text] [Related]
6. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
7. Frequent POLE1 p.S297F mutation in Chinese patients with ovarian endometrioid carcinoma.
Zou Y; Liu FY; Liu H; Wang F; Li W; Huang MZ; Huang Y; Yuan XQ; Xu XY; Huang OP; He M
Mutat Res; 2014 Mar; 761():49-52. PubMed ID: 24472300
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing reveals potential germline and somatic mutations in 60 malignant ovarian germ cell tumors†.
Chen J; Li Y; Wu J; Liu Y; Kang S
Biol Reprod; 2021 Jul; 105(1):164-178. PubMed ID: 33739378
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors.
Ichikawa Y; Yoshida S; Koyama Y; Hirai M; Ishikawa T; Nishida M; Tsunoda H; Kubo T; Miwa M; Uchida K
Int J Cancer; 1996 Dec; 69(6):466-70. PubMed ID: 8980248
[TBL] [Abstract][Full Text] [Related]
10. Genetic changes in nonepithelial ovarian cancer.
Van Nieuwenhuysen E; Lambrechts S; Lambrechts D; Leunen K; Amant F; Vergote I
Expert Rev Anticancer Ther; 2013 Jul; 13(7):871-82. PubMed ID: 23875665
[TBL] [Abstract][Full Text] [Related]
11. Mixed ovarian germ cell tumor in a BRCA2 mutation carrier.
Hamel N; Wong N; Alpert L; Galvez M; Foulkes WD
Int J Gynecol Pathol; 2007 Apr; 26(2):160-4. PubMed ID: 17413983
[TBL] [Abstract][Full Text] [Related]
12. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
McConechy MK; Anglesio MS; Kalloger SE; Yang W; Senz J; Chow C; Heravi-Moussavi A; Morin GB; Mes-Masson AM; ; Carey MS; McAlpine JN; Kwon JS; Prentice LM; Boyd N; Shah SP; Gilks CB; Huntsman DG
J Pathol; 2011 Apr; 223(5):567-73. PubMed ID: 21381030
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic analysis of bilateral ovarian germ cell tumors.
Hennes E; Zahn S; Lopes LF; Schönberger S; Leuschner I; Göbel U; Calaminus G; Schneider DT
Klin Padiatr; 2012 Oct; 224(6):359-65. PubMed ID: 23143763
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations of PPP2R1A in ovarian and uterine carcinomas.
Shih IeM; Panuganti PK; Kuo KT; Mao TL; Kuhn E; Jones S; Velculescu VE; Kurman RJ; Wang TL
Am J Pathol; 2011 Apr; 178(4):1442-7. PubMed ID: 21435433
[TBL] [Abstract][Full Text] [Related]
15. KRAS and MAPK1 gene amplification in type II ovarian carcinomas.
Rahman MT; Nakayama K; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Sato E; Iida K; Nakayama N; Ishikawa N; Miyazaki K
Int J Mol Sci; 2013 Jul; 14(7):13748-62. PubMed ID: 23820584
[TBL] [Abstract][Full Text] [Related]
16. Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states.
Lee JW; Yang WS; Chung SY; Kang JH; Cho B; Kim HK; Kim KM; Jeong DC
J Pediatr Hematol Oncol; 2007 Jun; 29(6):412-5. PubMed ID: 17551405
[TBL] [Abstract][Full Text] [Related]
17. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.
Fragoso MC; Latronico AC; Carvalho FM; Zerbini MC; Marcondes JA; Araujo LM; Lando VS; Frazzatto ET; Mendonca BB; Villares SM
J Clin Endocrinol Metab; 1998 Jun; 83(6):2074-8. PubMed ID: 9626141
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers.
Williams LH; Choong D; Johnson SA; Campbell IG
Clin Cancer Res; 2006 Dec; 12(23):6967-72. PubMed ID: 17145815
[TBL] [Abstract][Full Text] [Related]
19. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
[TBL] [Abstract][Full Text] [Related]
20. Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing's disease.
Sahakitrungruang T; Srichomthong C; Pornkunwilai S; Amornfa J; Shuangshoti S; Kulawonganunchai S; Suphapeetiporn K; Shotelersuk V
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1487-92. PubMed ID: 24823459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
